Reduction of nutrient run-off by the use of coated slow-release fertilizers on two container-grown nursery crops

The agricultural district of Pistoia (Tuscany, Italy) is one of the most important sites in Europe for the production of Hardy Ornamental Nursery Stock (HONS). One of the main problems of this sector is the environmental impact of the pot cultivation, mainly due to an incorrect irrigation scheduling that leads to high nitrogen and phosphorus losses. The aim of this research has been to compare the effects of the traditional fertigation versus new fertilization strategies, based on the use of controlled slow-release fertilizers (CRFs), on plant growth and on nitrogen and phosphorus run-off in two container HONS species (Photinia × fraseri and Prunus laurocerasus). Every week, plant height, cumulate irrigation and drainage volume were measured on four replicates for each treatment and species. Every four weeks two average samples of drainage water and irrigation water for each treatment and species were analysed, determining total nitrogen and phosphorus content, in order to draft a water and nutrient balance. The three different fertilization strategies did not produce any relevant effect on the final plant height and all plants were ranked in the top quality market category. The data confirmed that the use of CRFs could contribute to a huge reduction of nitrogen and phosphorus run-off in the environment and could be a winning strategy for the fertilization of HONS in nitrate vulnerable zones

uPAR controls vasculogenic mimicry ability expressed by drug-resistant melanoma cells.

Malignant melanoma is a highly aggressive skin cancer characterized by an elevated grade of tumor cell plasticity. Such plasticity allows adaptation of melanoma cells to different hostile conditions and guarantees tumor survival and disease progression, including aggressive features such as drug resistance. Indeed, almost 50% of melanoma rapidly develop resistance to the BRAF(V600E) inhibitor vemurafenib, with fast tumor dissemination, a devastating consequence for patients’ outcomes. Vasculogenic mimicry (VM), the ability of cancer cells to organize themselves in perfused vascular-like channels, might sustain tumor spread by providing vemurafenib-resistant cancer cells with supplementary ways to enter into circulation and disseminate. Thus, this research aims to determine if vemurafenib resistance goes with the acquisition of VM ability by aggressive melanoma cells, and identify a driving molecule for both vemurafenib resistance and VM. We used two independent experimental models of drug-resistant melanoma cells, the first one represented by a chronic adaptation of melanoma cells to extracellular acidosis, known to drive a particularly aggressive and vemurafenib-resistant phenotype, the second one generated with chronic vemurafenib exposure. By performing in vitro tube formation assay and evaluating the expression levels of the VM markers EphA2 and VE-cadherin by Western blotting and flow cytometer analyses, we demonstrated that vemurafenib-resistant cells obtained by both models are characterized by an increased ability to perform VM. Moreover, by exploiting the CRISPR-Cas9 technique and using the urokinase plasminogen activator receptor (uPAR) inhibitor M25, we identified uPAR as a driver of VM expressed by vemurafenib-resistant melanoma cells. Thus, uPAR targeting may be successfully leveraged as a new complementary therapy to inhibit VM in drug-resistant melanoma patients, to counteract the rapid progression and dissemination of the disease

Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases

n/